SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-000288
Filing Date
2019-01-03
Accepted
2019-01-03 16:22:53
Documents
2
Period of Report
2019-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7839
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4724
  Complete submission text file 0000899243-19-000288.txt   13918
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CRISPR THERAPEUTICS AG 610 MAIN STREET 7TH FLOOR CAMBRIDGE MA 02139
Business Address
Klein Lawrence Otto (Reporting) CIK: 0001762583 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 19505803